229 related articles for article (PubMed ID: 19126965)
1. Altered glycosylation in tumours focused to cancer diagnosis.
Peracaula R; Barrabés S; Sarrats A; Rudd PM; de Llorens R
Dis Markers; 2008; 25(4-5):207-18. PubMed ID: 19126965
[TBL] [Abstract][Full Text] [Related]
2. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
Chugh S; Gnanapragassam VS; Jain M; Rachagani S; Ponnusamy MP; Batra SK
Biochim Biophys Acta; 2015 Dec; 1856(2):211-25. PubMed ID: 26318196
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation markers in cancer.
Silsirivanit A
Adv Clin Chem; 2019; 89():189-213. PubMed ID: 30797469
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
5. Glycoproteins in the Sera of Oncological Patients.
Hernychová L; Uhrík L; Nenutil R; Novotný MV
Klin Onkol; 2019; 32(Supplementum 3):39-45. PubMed ID: 31627705
[TBL] [Abstract][Full Text] [Related]
6. O-glycosylated clusterin as a sensitive marker for diagnosing early stages of prostate cancer.
Kazuno S; Fujimura T; Fujime M; Miura Y; Ueno T
Prostate; 2021 Feb; 81(3):170-181. PubMed ID: 33347638
[TBL] [Abstract][Full Text] [Related]
7. Glycans and glycoproteins as specific biomarkers for cancer.
Kailemia MJ; Park D; Lebrilla CB
Anal Bioanal Chem; 2017 Jan; 409(2):395-410. PubMed ID: 27590322
[TBL] [Abstract][Full Text] [Related]
8. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
[TBL] [Abstract][Full Text] [Related]
9. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
10. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
11. Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum.
Terävä J; Verhassel A; Botti O; Islam MK; Leivo J; Wittfooth S; Härkönen P; Pettersson K; Gidwani K
Cancer Rep (Hoboken); 2022 Aug; 5(8):e1540. PubMed ID: 34423573
[TBL] [Abstract][Full Text] [Related]
12. Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification.
Kuno A; Kato Y; Matsuda A; Kaneko MK; Ito H; Amano K; Chiba Y; Narimatsu H; Hirabayashi J
Mol Cell Proteomics; 2009 Jan; 8(1):99-108. PubMed ID: 18697734
[TBL] [Abstract][Full Text] [Related]
13. A serum glycomics approach to breast cancer biomarkers.
Kirmiz C; Li B; An HJ; Clowers BH; Chew HK; Lam KS; Ferrige A; Alecio R; Borowsky AD; Sulaimon S; Lebrilla CB; Miyamoto S
Mol Cell Proteomics; 2007 Jan; 6(1):43-55. PubMed ID: 16847285
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous estimation of the association constants of glycoprotein glycoforms to a common protein by capillary electrophoresis.
Uegaki K; Taga A; Akada Y; Suzuki S; Honda S
Anal Biochem; 2002 Oct; 309(2):269-78. PubMed ID: 12413461
[TBL] [Abstract][Full Text] [Related]
15. Development of fully functional proteins with novel glycosylation via enzymatic glycan trimming.
Toumi ML; Go EP; Desaire H
J Pharm Sci; 2009 Aug; 98(8):2581-91. PubMed ID: 19117044
[TBL] [Abstract][Full Text] [Related]
16. Glycosylation products in prostate diseases.
Dos Santos Silva PM; Albuquerque PBS; de Oliveira WF; Coelho LCBB; Dos Santos Correia MT
Clin Chim Acta; 2019 Nov; 498():52-61. PubMed ID: 31400314
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
[TBL] [Abstract][Full Text] [Related]
18. Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy.
Taylor-Papadimitriou J; Epenetos AA
Trends Biotechnol; 1994 Jun; 12(6):227-33. PubMed ID: 7765069
[TBL] [Abstract][Full Text] [Related]
19. Alterations in glycosylation as biomarkers for cancer detection.
Reis CA; Osorio H; Silva L; Gomes C; David L
J Clin Pathol; 2010 Apr; 63(4):322-9. PubMed ID: 20354203
[TBL] [Abstract][Full Text] [Related]
20. Glycosylated proteins with abnormal glycosylation changes are potential biomarkers for early diagnosis of breast cancer.
Chang X; Obianwuna UE; Wang J; Zhang H; Qi G; Qiu K; Wu S
Int J Biol Macromol; 2023 May; 236():123855. PubMed ID: 36868337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]